Purpose/Aim of Study: Menisectomies account for over 1.5 million surgical interventions in Europe annually and there is a growing interest in regenerative strategies to improve outcomes in meniscal replacement. The overall objective of this study was to evaluate the role of intraoperatively applied fresh chondrocyte isolates compared to minced cartilage fragments, used without cell isolation, to improve bioactivity and tissue integration when combined with a polyurethane replacement.
Introduction
Meniscal injury poses a significant health burden with an estimated 1.5 million surgical interventions performed in Europe annually (1) . The meniscus plays a pivotal role in load transfer and knee stabilisation during normal joint motion. Damage to the meniscus exposes articular surfaces to excessive peak stresses and predisposes them to cartilage degeneration and progressive osteoarthritis (2, 3) . In pursuit of a feasible clinical substitute for damaged meniscus, clinical evidence supports the use of fresh frozen allografts (4) (5) (6) or as an alternative, synthetic meniscus replacements such as the Collagen Meniscus Implant (Ivy Sports Medicine) (7) (8) (9) or Actifit® (a polyurethane meniscus implant; Orteq) (10) . This polyurethane scaffold, through its unique combination of a porous structure and polymer strength, promotes ingrowth of new tissue (11) and has been shown to relieve pain and symptoms. However, even under ideal conditions, failure rates remain as high as 30% (12) . These approaches lack universal clinical efficacy with limitations surrounding graft shrinkage, inadequate attachment, lack of host tissue integration and subsequent myxoid degeneration (13) . To improve outcomes in surgical meniscal replacement and to maintain joint health, there is a growing interest in regenerative strategies.
Delivery of a regenerative solution may be possible through biological augmentation of existing synthetic acellular replacements. The incorporation of a cellular component providing extracellular matrix (ECM) elaboration can improve host tissue integration with enhanced bioactivity (14) . In applying a biomimetic approach, cells should reconstitute similar matrix components to maximise the amount of matrix deposited at the tissue-replacement interface to provide biological strength (15) . In assessing appropriate cell sources, Marsano et al (16) demonstrated articular chondrocytes to be effective in tissue reconstitution with higher levels of matrix components, sulphated glycosaminoglycans (sGAG) and collagen type II when compared to cells derived from human inner meniscal, fat pad and synovial membrane.
Previous work has shown that differentiated primary cell populations can adapt to microenvironmental cues, retain phenotypic expression and regenerative potential in vivo without the need for exogenous growth factor supplementation (17) . Interestingly, Mumme et al recently demonstrated the use of autologous nasal chondrocyte constructs to repair cartilage defects in human studies (18) . Equally, regenerative ventures using articular chondrocytes have also been successfully demonstrated with Matrix-induced Autologous Chondrocyte Implantation (MACI) and DeNovo® ET cartilage derived tissue implants for cartilage regeneration (19, 20) .
Given the need for large populations of viable chondrocytes and low cell yields from cartilage biopsies, laboratory based monolayer expansion had been the standard in the use of autologous chondrocytes to date. However, high costs and technical expertise required for GMP biomanufacturing facilities and concerns with respect to cellular dedifferentiation (21) , constrains or restricts the clinical application and efficacy of such approaches to specialist centres (22) . In addition, there is a need for two surgical procedures; one for tissue harvest and a second procedure for subsequent implantation of a cell-seeded or tissue engineered construct.
This increases the associated costs, risk of infection and other complications for patients. As such, incorporation of fresh biologics amenable to intraoperative processing and single step interventions could be cost effective and facilitate favourable logistics for widespread application (23) .
The development of an intraoperative cell processing protocol and devices to optimize cell yield for fresh delivery and regeneration, may hold potential in this regard. There remains significant variation in the literature, proposing altering combinations of enzyme regimes, multistep isolations, enzyme concentrations and incubation times to improve cell yields (24).
We have recently developed a protocol for rapid isolation of nasal chondrocytes, whereby manipulating time and concentration of collagenase exposure in combination with intermittent physical agitation, we could obtain clinically relevant cell yields for tissue regeneration strategies (25) . Similarly, the success of such protocols has previously been demonstrated for cartilage regeneration (26) . These protocols could potentially be adopted to yield an intraoperative strategy for articular cartilage processing and application to improve integration of a meniscal replacement. For example, Numpaisal et al explored the use of rapidly dissociated meniscal cartilage with 0.2% collagenase in a 3D fibrin hydrogel to repair meniscal defects (27) . However, minced meniscal tissue was subject to enzymatic digestion to yield the rapidly dissociated tissues in this study. While this allows for single stage application, the regulatory landscape for the intraoperative use of enzymes may limit widespread clinical adoption. 
Materials and Methods

Rapid isolation of articular chondrocytes from caprine knee joint tissue
Caprine knee joints were obtained from a local farm within 6 h of sacrifice. Biopsies of articular cartilage were harvested from both condyles at random, washed with phosphate buffered saline (PBS) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin (P/S) (GIBCO, Invitrogen, Dublin, Ireland) and minced. These biopsies were minced to approximately 1mm size pieces. Half of these were subject to enzymatic digestion with physical agitation as outlined previously to harvest FC while the other half were used as minced cartilage in this study. Phase 1: Tissues for enzymatic digestion were subjected to either 750 units of activity/ml (U/ml) or 3000 U/ml collagenase type II (Gibco, Dublin, Ireland) at a ratio of 10 ml per g of (100 U/ml)-streptomycin (100 mg/ml) and amphotericin B (0.25 mg/ml, Sigma-Aldrich, Dublin, Ireland) ( Fig.1 , Phase II). Cultures were expanded to passage one (P1) (7 days from initial isolation) in a humidified atmosphere at 37 °C, 5% O2 and 5% CO2.
Determination of proliferation kinetics
When subconfluent (~80%), ECs were detached by treatment with 0.05% trypsin/0.53 mM ethylenediaminetetraacetic acid (EDTA) (all Sigma-Aldrich, Dublin, Ireland) and counted using trypan blue exclusion. The number of cell doublings during the expansion phase was determined as the logarithm (base 2) of the fold increase in the number of cells during expansion. The population doubling time was defined as the culture expansion time divided by the number of doublings during the expansion phase (30).
Cell seeding onto polyurethane scaffolds
Cylindrical constructs (2 x 2 mm) were obtained by coring of entire Actifit® implants using a standard 2mm biopsy punch. Cells were seeded onto polyurethane scaffolds to assess matrix deposition by rapidly isolated cells, as FC or EC (Fig. 1 , Phase II). FC and EC were resuspended in 20 μl of media at a concentration of 5x10 6 cells/ml (100,000 cells/scaffold) and loaded onto scaffolds. Culture media used for seeding consisted of high glucose (HG)
Dulbecco's Modified Eagle Medium (Gibco, Invitrogen, Dublin, Ireland) with 10% fetal bovine serum (Gibco, Invitrogen, Dublin, Ireland), 50 µg/ml L-ascorbic acid-2-phosphate, penicillin (100 U/ml)-streptomycin (100 mg/ml) and amphotericin B (0.25 mg/ml, SigmaAldrich, Dublin, Ireland) at 37 °C and 5% CO2. Scaffold constructs were incubated for 30 min to facilitate cellular attachment and subsequently a further 2 mL of the same media was added to each well. Scaffolds were incubated at 37 °C, 5% O2 and 5% CO2 for up to 28 days.
Isolation and culture of meniscal explants from caprine knee joints
A previously described meniscal replacement model system (31-33) was employed to assess ex vivo integrative meniscal replacement (n = 3 per treatment group, all from different animals).
A schematic representation of the experimental setting is shown in Fig.1 , Phase III. Explants (5 mm diameter) were cored from caprine menisci. To simulate a full-thickness tear, a 2 mm concentric core defect was introduced in the intermediate zone using a custom made double punch. The central core was removed and discarded. Explants were cut parallel to the meniscal surface with a scalpel to a uniform thickness of 2 mm using a custom-made cutting block.
Immediately after harvest, samples were incubated in 12-well plates in 4 mL of culture media consisting of high glucose (HG) Dulbecco's Modified Eagle Medium (Gibco, Invitrogen) with 10% fetal bovine serum (Gibco, Invitrogen), 0.1 mM nonessential amino acids (Gibco), 400 µg/ml L-proline, 50 µg/ml L-ascorbic acid-2-phosphate, penicillin (100 U/ml)-streptomycin (100 mg/ml) and amphotericin B (0.25 mg/ml, Sigma-Aldrich) at 37 °C and 5% CO2. Samples were cultured for 48 h to allow equilibration of cell metabolic activity in culture. Subsequently, 20 µl of either FC (100,000 cells/scaffold) or MC (50 mg/scaffold ) were loaded onto scaffolds, incubated for 30 min as described earlier, press-fit into meniscal explants and subsequently transferred to culture media (n=6/group) with acellular scaffolds serving as controls (n=6/group). Media changes were performed every 3-4 days, with explants cultured for a total of 28 days at 37 °C and 5% O2.
Assessment of cell viability
Cell viability was assessed using a viability/cytotoxicity assay kit (LIVE/DEAD®, Invitrogen, Dublin, Ireland) in accordance with the manufacturer's protocol. Briefly, constructs were cut in half, washed in PBS followed by incubation in PBS containing 2 μM calcein AM (live, intact cell membrane) and 4 μM ethidium homodimer-1 (dead, disrupted cell membrane).
Sections were again washed in PBS, imaged with a Leica SP8 Confocal Microscope, Wetzlar, Germany with a Z stack encompassing the depth of the scaffold at 515 and 615 nm channels and analysed using Leica LAS X Core Software, Wetzlar, Germany.
Quantitative biochemical analysis
On removal from culture, wet weight of the scaffolds was recorded and constructs were frozen at -85 C for further analysis. Samples were digested with 125 μg/mL papain in 0.1 M sodium acetate, 5 mM L-cysteine-HCl, 0.05 M EDTA, pH 6.0 (all from Sigma-Aldrich, Dublin, Ireland) at 60 °C under constant rotation for 18 h. DNA content was determined using the Hoescht 33258 dye-based assay (DNA QF Kit, Sigma-Aldrich, Dublin, Ireland) with a calf thymus DNA standard. Proteoglycan (sulphated glycosaminoglycan, sGAG) content was quantified using the dimethylmethylene blue dye-binding assay (Blyscan, Biocolor Ltd., Dublin, Ireland), with a chondroitin sulphate standard. Total collagen was determined by measuring the hydroxyproline content. Samples were hydrolysed at 110 °C for 18 h with an equal volume of concentrated (38%) HCl and assayed using a chloramine-T assay (34) with a hydroxyproline:collagen ratio of 1:7.69 (35) . Each biochemical constituent was normalised to the tissue wet weight (%w/w).
Histological Analysis
Constructs were removed from culture, washed in PBS and fixed with 4%
paraformaldehyde solution overnight at room temperature. After removing fixative, samples were rinsed with PBS, and embedded using optimum cutting temperature (OCT) cryoembedding compound. Routine cryosectioning was performed on frozen blocks (8 μm cross-sections along the longitudinal plane) using a cryostat (Leica CM 1850, Wetzlar, Germany) at −21 °C. sGAG deposition was evaluated using 1% alcian blue 8GX in 0.1 M HCL, collagen distribution was assessed using picro-sirius red (all from Sigma-Aldrich, Dublin, Ireland). Collagen type II was evaluated through immunohistochemistry. Briefly, sections were treated with peroxidase, followed by treatment with chondroitinase ABC (Sigma -Aldrich, Dublin, Ireland) in a humidified environment at 37°C to enhance permeability of the ECM. Sections were incubated with goat serum to block nonspecific sites and primary antibody (mouse monoclonal, Abcam, Cambridge, UK) were applied for 18h at 4°C. Next, the secondary antibody (Anti-Mouse IgG biotin conjugate 1:200; 2.1mg/ml) (Sigma Aldrich, Dublin, Ireland) was added for 1h followed by incubation with ABC reagent (Vectastain PK400, Vector Labs, Peterborough, UK) for 45min. Colour was developed using the Vectastain ABC reagent followed by exposure to peroxidase DAB substrate kit (Vector Labs, Peterborough, UK).
Positive and negative controls of ligament and cartilage were incubated for each batch ( Supplementary Fig. 1 ). Sections were imaged with an Olympus IX51 inverted microscope fitted with an Olympus DP70 camera (all Olympus, Waltham, MA, USA).
Biomechanical testing
After 28 days of culture, the integration strength between the outer ring and inner core of meniscal explants was quantified using a push-out test as previously described (31) (32) (33) .
Briefly, explants were centered in a custom-made holder, such that the 2 mm inner core was centered over a 2.5 mm concentric hole in the bottom of the dish. Using a standard materials testing machine (Zwick Z005, Roell, Germany), a flat round shaped indenter with a diameter of 1.8 mm attached to a 5N load cell displaced the inner core at a rate of 2% strain per minute until the inner core was dislodged from the outer ring and a sharp fall in force was observed.
The force required for displacement was recorded over time. Integration strength (in kPa) was calculated by dividing the peak force required to push the inner core through the outer annulus measured during the push out test by the surface area of the interface.
Statistical analysis
Statistical analyses were performed using GraphPad Prism (version 5) software with 3-4 samples analysed for each experimental group. One-way or two-way ANOVA was used for analysis of variance with Bonferroni's post-tests to compare between groups. Graphical results are displayed as mean ± standard deviation from three independent donors. Significance was accepted at a level of P < 0.05.
Results
Rapid chondrocyte isolation and characterisation
The relationship between biopsy size and weight was determined to assess the clinical validity and relevance of obtaining a cartilage biopsy from a non-load bearing region of the knee similar to that performed for ACI. For typical ACI procedures, approximately 300-500 mg of tissue is harvested for cell isolation (17) , implying that a minimum biopsy size of 3mm is required (Fig. 2A) . Cell yield was optimized for articular cartilage incorporating physical agitation to investigate the effect of enzyme exposure for three incubation times of 30 min, 1 h and 12 h, with a low (750 U/ml ) and high (3000 U/ml) collagenase type II concentration as described previously by our laboratory (25) . With 3000U/ml of enzyme, the cell yield ( Fig.   2B ) was found to improve 5 fold in 30 min and 1 h digest times compared with 750 U/ml (P<0.0001). Cell yield was increased 2 fold (~2.5x10 6 to 5x10 6 per g of cartilage) when increasing the incubation time from 30 min to 1 h at 3000 U/ml with a minor (4.74%) reduction in cell viability (P<0.05) (Fig. 2C ). Increased temporal exposure had more of an effect on cell yield than enzyme concentration after 12 h (Fig. 2B) , although cell viability was significantly reduced for both enzyme concentrations (Fig. 2C ) (P<0.0001). Further, when assessing proliferation kinetics in terms of population doubling time (Fig. 2D) , the rapidly isolated group (30 min 3000U/ml) was found to display significantly faster doubling kinetics (~2 fold) when compared with the standard isolation group (12 h 750U/ml) (P<0.001). Taken together, results
suggest that the number of cells that can be isolated from biopsies of joint cartilage ranges from 0.75 x10 6 (3mm biopsy) to 1.25 x10 6 (4mm biopsy) which can be used for subsequent tissue regeneration approaches.
Cell proliferation, viability and matrix forming capacity of freshly isolated and culture expanded cells
Having demonstrated the feasibility of fresh cell isolation, we next sought to compare FC (30 min isolation protocol, 3000U/ml collagenase concentration) and EC in terms of proliferation and matrix deposition. FC seeded constructs group exhibited higher (1.5 fold)
DNA content (Fig. 3A) compared to EC seeded constructs (P<0.001). LIVE-DEAD imaging revealed a higher density of cells in FC constructs compared to the EC (Fig. 3D) . ECM matrix deposition was subsequently evaluated in terms of sGAG and collagen accumulation. Higher sGAG accumulation (~55%) was observed for FC compared to EC seeded constructs (P<0.001) in terms of sGAG (% w/w) and sGAG/DNA (Fig. 3B) . This was also confirmed through histology staining with more intense alcian blue staining in FC compared to EC constructs (Fig.   3E ). Similar trends were also observed for collagen with increased accumulation for FC compared to EC constructs in terms of Collagen (% w/w) and Collagen/DNA (P<0.05) (Fig.   3C ), which was also evident upon histological evaluation (Fig. 3F ).
Cell viability of freshly isolated chondrocytes and minced cartilage in a meniscal explant culture model
Having demonstrated FC isolates to be superior to standard EC in terms of matrix elaboration, we next sought to directly compare the use of FC to MC, which is an equally feasible strategy for intraoperative use obviating the need for enzymatic cell isolation. Both MC and FC were loaded onto polyurethane scaffolds (2x2mm) and cultured in an explant defect model, with acellular scaffolds serving as controls. Following explant culture for 28 days, some cell migration into the acellular implant was observed, although lower cell numbers and diminished viability were observed at the tissue interface (Fig. 4A, top) . With increasing distance from the scaffold-tissue interface, higher cell numbers were evident within both MC (Fig. 4A , middle) and FC (Fig. 4A bottom) . Specifically, FC constructs exhibited the highest cell density, which was further reflected in the DNA biochemical quantification (Fig. 4B ).
Matrix forming capacity in explant culture of acellular, minced cartilage and rapidly isolated chondrocytes
Increased amounts of sGAG was observed in MC and FC constructs, with FC exhibiting ~3 fold higher levels of FC and ~2 fold higher for MC compared to acellular controls (P<0.0001) (Fig. 5A ) in terms of sGAG (% w/w) and sGAG/DNA. Based on histological evaluation of the interface, more intense staining was observed for FC when compared with MC groups, with negligible deposition observed at the interface for acellular constructs (Fig.   5B ).
In evaluating collagen accumulation, collagen deposition was 25% higher for FC constructs (P<0.0001) compared with MC which was 50% higher (P<0.0001) compared to acellular controls (Fig. 5C ) in terms of both collagen (%w/w) and collagen/DNA. Similarly, intense collagen staining was observed at the tissue-construct interface for both FC and MC constructs with negligible deposition evident at the interface for acellular controls (Fig. 5D ).
Additionally, on evaluation of collagen type II deposition through immunohistochemistry, positive staining was observed at the tissue construct interface and was more intense for FC compared to MC, with minimal staining present at the interface of acellular controls (Fig 5E) .
Interface integration strength in explant culture of fresh, rapidly isolated chondrocytes and minced cartilage
Finally, to assess functional improvements at the replacement-tissue interface, the push-out strength was determined by means of a pushout test as shown in Fig. 6A . The integration strength of the interface was found to be 4 fold higher for FC constructs (81.9 ±19.4 kPa) and 2.5 fold greater for MC groups (58.0 ±15.2 kPa) compared to the acellular implant (21.6 ±13.3 kPa ) only (Fig. 6B ).
Discussion
The burden of meniscal pathology in active and aging populations extends to chronic repercussions in joint degeneration and osteoarthritis. Acellular scaffold replacements have been shown to improve pain, functional and radiological outcomes, but there remain limitations with delamination and failure. The potential of combining biological augmentation with commercially available polyurethane scaffolds is highly attractive to overcome some of the associated limitations such as graft shrinkage, inadequate attachment and host tissue integration (14, 36) . Therefore, there is an ever-growing need for low cost and viable interventions to improve tissue integration and replacement of defects. Current approaches in regenerative joint therapeutics utilising chondrocytes have not been widely adopted perhaps due to the time, costs and expertise required for cell expansion (37) . In this context, intraoperative point of care
(POC) biologics amenable to single step interventions appear attractive and may provide an alternative and viable strategy (38) .
The overall aim of this study was to assess the role of intraoperative cartilage derived proliferation, and matrix deposition at the interface site, without the need for exogenous growth factor supplementation (42, 43) . In addition, clinical parameters and economic feasibility considerations will be vital to the widespread adoption of regenerative approaches to benefit patients. Incorporating such considerations from the outset in the in vitro conceptualisation of approaches can be beneficial (23) . Biological augmentation strategies attempt to overcome the inherent limitations in healing related to poor vascularity and heterogeneous cellularity. Thus, single step intraoperative cartilage based biologics applied to existing commercial synthetic implants such as the polyurethane scaffold (10, 11, 44, 45) can improve bioactivity and render favourable logistics to improve meniscal repair or replacement.
However, low cells yields from cartilage digests remains a key limitation. The heterogeneity of chondrocyte isolation and poor consistency in reporting enzyme units in the literature limit the delivery of optimized protocols for intraoperative processing (24, 25). To address this, a protocol previously developed in our laboratory for rapid cell isolation from nasal cartilage (25) was applied to articular cartilage. Improved cell yields were observed for articular cartilage with a cell yield of 2-2.5 x 10 6 cells/g from a clinically relevant biopsy (~300 mg) (17) using a reduced isolation time of 30 min. This is comparable to previous work by Bekkers et al. who report similar cell yields 0.56-1.06 x 10 6 cells/g (26) . Exposure time was found to be more detrimental to cell viability than concentration as previously demonstrated by Bos et al (46) . Previous work in our laboratory has also shown that higher exposure time (12 hrs) of tissue to enzymes is also detrimental to subsequent chondrogenesis of nasal chondrocytes, while short incubation times using high enzyme concentrations (3000U/ml) for 1 hr combined with physical dissociation results in robust matrix formation (25) . In the current study, we demonstrate further improvements in cell viability using a 30 min isolation regime, when compared with a 1 h protocol at 3000 U/ml or 750 U exposure for 12 h. Reduced population doubling time was observed for chondrocytes isolated using short term, high enzyme concentration exposure compared with conventional chondrocyte isolation protocols.
This data suggests that rapidly isolated cells, which may be available in lower numbers for implantation are capable of superior proliferation (47) . Improved cell vitality and matrix forming capacity were confirmed with higher levels of sGAG and collagen accumulation of freshly derived isolates (i.e. FC) on a polyurethane compared with tissue culture expanded chondrocytes (i.e. EC). In addition to improved proliferation of FC over MC, higher sGAG/DNA and Collagen/DNA ratios demonstrate that increased cell metabolism and higher matrix production of individual cells is also contributing to the higher overall amounts of matrix accumulation. This is in keeping with our previous observations with rapidly isolated fresh nasal chondrocytes whereby greater attrition of pericellular matrix (PCM) with prolonged digest times is seen to result in higher metabolism of cells (25) . Herein, we observe both diminished proliferation and reduced matrix turnover with minced cartilage in comparison to isolated cells. This would favour the use of fresh chondrocytes to achieve higher levels of matrix reconstitution.
As proposed by Numpaisal et al (27) , an advantage of utilising articular chondrocytes is the similar matrix composition between the inner meniscus and hyaline cartilage. Similarly, in this study, we observed collagen accumulation for both FC and MC, and importantly this was predominantly Collagen Type II, which is the desired collagen type for meniscus regeneration.
In this manner, the application of fresh chondrocyte based biologics demonstrates the Where the use of enzymatic isolation protocols intraoperatively is largely reliant on the evolving regulatory landscapes, the efficacy of tissue transplantation with minced cartilage without the need for enzymatic cell isolation has been demonstrated in cartilage approaches (26, 29) . However, to the best of the authors' knowledge, the application of such has not been applied to meniscal replacement procedures. In comparing both FC to MC in a meniscal explant defect model, improved proliferation, sGAG and collagen production was observed compared with the acellular implant. 
Conclusion
The application of regenerative orthobiologics in the clinical setting may offer significant potential in augmenting synthetic replacements to address the demands of meniscal surgery. 
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